Fc Receptor Inhibition Reduces Susceptibility to Oxidative Stress in Human RPE Cells Treated with Bevacizumab, but not Aflibercept

Publisher: Karger

E-ISSN: 1421-9778|38|2|737-747

ISSN: 1015-8987

Source: Cellular Physiology and Biochemistry, Vol.38, Iss.2, 2016-0, pp. : 737-747

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content